;
MRI DYE CONTAINING GADOLINIUM
Intro
Symptoms
FDA
COI
COI Continued
Research
Steps
Patient Perspective
Etc.
Blog
Howard A. Rowley
University of Wisconsin
“IS A CONSULTANT FOR BRACCO, GUERBET, BAYER, AND GE HEALTHCARE; INSTITUTION RECEIVED GRANTS FROM BRACCO AND GUERBET; GAVE LECTURES FOR BRACCO, BAYER, AND GE HEALTHCARE; HAS A PATENT WITH GE HEALTHCARE; RECEIVED COMPENSATION FOR TRAVEL FROM BRACCO, GUERBET, AND GE HEALTHCARE. OTHER RELATIONSHIPS: HAS A PATENT PENDING WITH GE HEALTHCARE.”
ASNR 2015 PRESENTER "DIAGNOSTIC NEURORADIOLOGY PERSPECTIVE"
ASNR 2016 PROGRAM CHAIR / PRESIDENT ELECT
ASNR 2017 MODERATOR OF "INTRACRANIAL GADOLINIUM DEPOSITION: MUCH ADO ABOUT NOTHING?" PRESENTED BY ROBERT J MCDONALD
ASNR 2018 PRESENTER "GADOLINIUM IN NEUROIMAGING: TO GIVE OR NOT TO GIVE- WHAT IS THE EVIDENCE?
ASNR 2019 PRESENTATION "FACT VS FICTION: GADOLINIUM RETENTION.."
RSNA 2015, 2016, 2017, 2018 ANNUAL MEETING SPEAKER ON
NEURORADIOLOGY
NW IMAGING FORUM 2015 SYMPOSIUM "OPTIMIZATION OF CONTRAST USE"
- SPONSORED BY BRACCO
MEDSCAPE CME "ENHANCED MRI: SAFEGUARDING AN IMAGING GOLD STANDARD"
SPR EDUCATION FOUNDATION DONOR
MRI safety, MRI side effects, Gadolinium, Toxic, MRI Contrast, MRI Dye, Safety, GBCA, NSF, ACR, Fibromyalgia, Radiology, Linear, Macrocylic, CTE, Football CTE, Chronic Traumatic Encephalopathy, multiple sclerosis, brain injury